Bile acid CoA:amino acid N-acyltransferase (BAAT) is the terminal enzyme in the synthesis of bile salts from cholesterol and catalyzes the conjugation of taurine or glycine to bile acid CoA thioesters to form bile acid N-acylamidates. BAAT has a dual localization to the cytosol and peroxisomes, possibly due to an inefficient carboxy-terminal peroxisomal targeting signal (PTS) -serine-glutamine-leucine (-SQL). Mutational analysis was used to define the role of the carboxyterminus in peroxisomal localization and kinetic activity. Amidation activity of BAAT and BAAT lacking the final 2 AAs (BAAT-S) were similar, whereas the activity of BAAT with a canonical PTS sequence (B AAT-SKL) was increased >2.5-fold. Kinetic analysis of BAAT and BAAT-SKL showed that BAAT-SKL had a lower K m for taurine and glycine as well as a greater V max . There was no difference in the affinity for cholyl-CoA. In contrast to BAAT, BAAT-SKL forms bile acid N-acylamidates with β-alanine. BAAT-S immunoprecipitated when incubated with Pex5 and rabbit anti-Pex5 antibodies; however, deleting the final 12 AAs prevented coimmunoprecipitation with Pex5 indicating the Pex5 interaction involves more than the -SQL sequence. These results indicate that even small changes in the carboxy-terminus of BAAT can have significant effects on activity and substrate specificity.
Introduction
Bile acids are weak organic acids and the end products of cholesterol metabolism. Their role as biological detergents is critical for the digestion and solubilization of dietary fats and their metabolic products. Under normal physiological conditions, over 99% of bile acids in bile are found conjugated to the amino acids (AA) glycine and taurine (1) . Conjugation of bile acids with glycine or taurine lowers their pK a , facilitating excretion into bile and allowing the bile acids to maintain aqueous solubility in the wide range of pH conditions throughout the intestinal tract to ensure the absorption of fat and fat-soluble vitamins.
Bile acid amidation involves the successive action of two enzymes: bile acid CoA ligase (BAL) and bile acid CoA:amino acid N-acyltransferase (BAAT). BAL catalyzes the formation of a bile acid acyl-thioester between Coenzyme A (CoA) and a 27-or 24-carbon bile acid (2) .
BAAT mediates the conjugation of a CoA-activated bile acid with an amino acid in a reaction that involves two steps. In the first step, BAAT binds to the bile acid-CoA and hydrolyzes the thioester bond of the CoA moiety, transferring the bile acid linkage to a cysteine (Cys) residue in the enzyme. In the second step, BAAT catalyzes the addition of the amino acid to the bile acid, forming a bile salt (N-acylamidate) through an amide linkage. BAAT is a multifunctional enzyme that can catalyze reactions as a thioesterase or N-acyltransferase (3) . BAAT has been reported to use a catalytic triad of Cys-235, His-362, and Asp-328 (3), similar to the catalytic triads in thioesterase enzymes that use a Ser-His-Asp motif (4) . BAAT also has high homology (≥40%) to several peroxisomal, mitochondrial, and cytosolic long chain acyl-CoA thioesterases or acyl-CoA thioesterases (3, 4) .
To date, the investigation of the amino acid residues affecting BAAT activity has been limited to residues considered as part of the active site located near the interior of the protein (3).
The C-termini of N-acetyltransferases have been shown to be critical for activity, and the final three amino acids of BAAT are thought to associate with peroxisomal biogenesis factor 5 (Pex5) and facilitate translocation to peroxisomes (5, 6) . Approximately 25-30% of BAAT in by guest, on www.jlr.org Downloaded from 4 hepatocytes is localized to peroxisomes, the remainder is in the cytosol (7) (8) (9) . The majority of proteins targeted to peroxisomes utilize a three amino acid carboxy-terminal peroxisomal targeting signal (PTS)-1 sequence that interacts with Pex5 (10, 11) . Typically, the PTS-1 sequence is -serine/alanine-arginine/lysine-leucine/methionine [S/A]-[R/K]-[L/M] located at the C-terminus (12) ; however, BAAT contains a degenerate PTS-1 sequence, -SQL (13) . Since approximately 25% of BAAT is localized in peroxisomes (7-9), it was hypothesized that the BAAT -SQL sequence was responsible for a lower level of binding to Pex5 and thus a limited targeting of BAAT to peroxisomes. The current manuscript examines the changes in the activity and properties of BAAT conferred by specific mutations in the C-terminus of the protein.
Relatively minor changes in the sequence of BAAT at the C-terminus had significant effects on BAAT activity and substrate selectivity indicating the importance of this region in the catalytic properties of the enzyme. A point mutation in the penultimate C-terminal residue of BAAT, resulting in formation of a canonical Pex5 binding sequence (BAAT-SKL), increased amidation activity, thioesterase activity, and resistance to thermal inactivation. The PTS sequence was not necessary for interacting with Pex5 as evaluated by immunoprecipitation; however, this sequence plays an important role in the recognition of amino acids capable of conjugating the thiol-bile acid intermediate. 
Materials
Our laboratories have previously reported the cloning and expression of human liver BAAT (hBAAT) (13) , rat liver BAAT (rBAAT) (14) , and mouse liver BAAT (mBAAT) (15 were from Amersham Pharmacia Biotech (Piscataway, NJ). The rabbit anti-mouse BAAT antiserum was generated as described previously (14) . Cloned human Pex5S cDNA (AK225126) in a PCMV6-XL4 vector was purchased from Origene (Rockville, MD).
Methods

Construction of BAAT Mutants
To construct C-terminal mutants, a pKK233-2-hBAAT construct (13) was utilized for PCR mutagenesis. To disrupt the PTS-1 sequence, the Gln 417 residue was changed to a termination codon by converting nucleotide 1247 from a CT using the forward primer 
Bacterial Expression and Purification of Human BAAT
To obtain active purified hBAAT protein, an overnight culture of E. coli DH5α containing a pKK-hBAAT plasmid previously constructed by our laboratory (13) was diluted 1:100 in LB broth containing 100 μg/ml ampicillin. This culture was grown to an OD 600 = 0.5.
IPTG was added to a final concentration of 0.5 mM to induce expression of hBAAT, and the culture incubated an additional 2 hours (h). The culture was centrifuged at 3,000 x g for 15 minute (min) to pellet the bacteria; then the pellet was resuspended in bacterial lysis buffer (75 mM Tris, pH 8, 250 mM sucrose, 0.25 mM EDTA, 0.02 mg/ml lysozyme) and incubated for 20 min on ice. The lysate was centrifuged at 3,000 x g at 4˚C for 10 min, resuspended in TEA Buffer (10 mM triethanolamine pH 8, 1.5 mM DTT, 10% glycerol, protease inhibitors (Complete Mini, Roche Biosciences)), and sonicated on ice 4 times for 10 seconds (sec) each with 30 sec in between pulses. The lysed bacteria were centrifuged 100,000 x g for 1 h, and the resulting cytosolic fraction was retained.
For further purification of expressed hBAAT, the bacterial cytosol was loaded onto a 17 x 1.5 cm DEAE-Sepharose Cl-6B column. The column was washed with 30 ml of TEA Buffer, and hBAAT was eluted with a 0 to 200 mM NaCl gradient and collected in 3 ml fractions.
Fractions containing hBAAT were identified by BAAT activity assays and immunoblotting.
Fractions enriched in BAAT activity were pooled and used for characterization.
Immunoblot Analysis
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For immunoblot analysis, protein fractions (100 µg) were resolved by SDS-PAGE and electrotransferred to nitrocellulose membranes. Membranes were blocked with 5% nonfat milk followed by incubation with a 1:5,000 dilution of rabbit anti-mouse BAAT antibody described previously (14) or a commercially available goat anti-human Pex5 antibody (Santa Cruz).
Membranes were then incubated with a 1:20,000 dilution of goat anti-rabbit IgG conjugated with horseradish peroxidase (for BAAT antibody) or a 1:20,000 dilution of donkey anti-goat IgG conjugated with horseradish peroxidase (for Pex5 antibody). Immunoconjugates were visualized using the Supersignal West Pico System (Pierce).
Bacterial Expression and Purification of Human Pex5S
Cloned human Pex5S cDNA (AK225126) in a PCMV6-XL4 vector was purchased from and Sal I and ligated into pQE-31, which was digested using the same restriction sites. E. coli DH5α were transformed with the Pex5S-pQE vector, and Pex5S was expressed and purified in a similar manner as described for BAAT, with the exception of using a 0 to 500 mM NaCl gradient to elute the protein. Fractions containing Pex5S were identified via immunoblot analysis using a goat anti-human Pex5 antibody, and fractions containing high levels of Pex5S were pooled and stored at -70˚C until used.
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Immunoprecipitation
To immunoprecipitate Pex5, recombinant Pex5S protein (alone or in the presence of recombinant BAAT protein) was incubated for 3 h at 4˚C with Protein A Sepharose beads bound to a goat anti-human Pex5 antibody, according to the ExactaCruz protocol. After incubation, the beads were washed 3 times by resuspension in 500 μl 1X PBS followed by centrifugation at 5,000 x g before being dissolved in 2X Laemmli sample buffer. The samples were boiled for 5 min before undergoing SDS-PAGE analysis.
BAAT Activity Radioassay
BAAT amidation activity was determined using the radioassay described by were monitored to detect the formation of cholic acid and taurocholic acid.
To examine the reaction products of the different BAAT forms with nortaurine and homotaurine, the reaction described for the radioassay was used, but taurine was replaced by nortaurine or homotaurine. After incubation for 10 min, enzyme reactions were stopped by addition of 500 µl of methanol, and aliquots of the supernatant infused into the mass spectrometer in 50% methanol-0.1% acetic acid, recording negative mass spectra between m/z 400-600.
Results
hBAAT Mutants
To examine the role of the BAAT-SQL and the adjacent sequence in Pex5 binding and regulation of enzymatic activity, several sequence variants were made to the carboxy-terminal of 
Mutations in the C-terminus of hBAAT Affect Enzyme Activity
Investigation into the effect of these mutations on enzymatic activity was warranted due to the close proximity of carboxy-terminal mutations to the active site His-362 in BAAT (3).
BAAT is capable of catalyzing both N-acyltransferase and thioesterase reactions (3); therefore, simultaneous measurement of both activities was performed using wild-type BAAT, BAAT-S, BAAT-SKL, BAAT-12AA Trunc, and BAAT-Ex1Del. BAAT-SKL was found to have greater than a 2.5 fold increase in N-acyltransferase activity compared to wild-type BAAT using cholylCoA and taurine as substrates (Figure 2A) . Deletion of the final 2 amino acids in BAAT-S did not significantly alter N-acyltransferase activity as compared to wild-type BAAT. In contrast, BAAT-12AA Trunc and BAAT-Ex1Del possessed no detectable N-acyltransferase activity although both enzymes still showed thioesterase activity ( Figure 2A ). When thioesterase activities were measured by the production of free cholic acid, BAAT-SKL showed a 78% increase as compared to wild-type BAAT ( Figure 2B ). BAAT-S and BAAT-12AA Trunc also had thioesterase activities similar to wild-type BAAT. In contrast, BAAT-Ex1Del showed a 31% increase in thioesterase activity compared to wild-type BAAT ( Figure 2B ). Table 1 ). Wild-type BAAT and BAAT-SKL also had similar K M s for cholyl-CoA; however, the K M values determined for both taurine and glycine with BAAT-SKL were approximately 50% lower ( Figure 3 , Table 1 
Thermostability of BAAT In Vitro and In Vivo
Thermal inactivation of enzymatic activity can reflect changes in the structure of proteins and the stability of the tertiary structure. To discern the role of the carboxy-terminus of BAAT in the stability of N-acetyltransferase activity, purified BAAT, BAAT-S, and BAAT-SKL were incubated for increasing lengths of time at 42˚C before measuring N-acyltransferase activity.
BAAT-S showed a significant increase in the loss of N-acetyltransferase activity as compared to wild-type BAAT ( Figure 6 ). In contrast, hBAAT-SKL possessed a greater resistance to thermal inactivation than wild-type BAAT ( Figure 6 ). These results suggest that C-terminus of BAAT has a significant influence on the thermostability of the enzyme in vitro.
Pex5 Interacts with BAAT and Inhibits Activity
When the expressed BAAT mutants were resolved by SDS-PAGE, BAAT-12AA Trunc, and BAAT-Ex1Del exhibited electrophoretic mobilities different from the other forms of BAAT ( Figure 7A ). To determine whether Pex5 and the BAAT mutants could interact in vitro, purified wild-type BAAT and the four BAAT mutants were incubated with purified recombinant human Pex5S for 1 h at 37˚C, then immunoprecipitated with the goat anti-Pex5 antibody. The precipitates were then immunoblotted with the rabbit anti-BAAT antibody. Wild-type BAAT,
BAAT-S, BAAT-SKL, and BAAT-Ex1Del all immunoprecipitated after incubation with Pex5S
using the goat anti-Pex5 antibody, whereas hBAAT-12AA Trunc did not ( Figure 7B ).
Since Pex5 can bind to BAAT, apparently at the carboxy-terminus, and the last 12 amino acids of the carboxy-terminus are necessary for N-acyltransferase activity, Pex5 binding was evaluated for a role in the inhibition of N-acyltransferase activity in the BAAT mutants.
BAAT N-acyltransferase activity was measured after incubating purified wild-type BAAT,
BAAT-S, and BAAT-SKL with varying levels of purified recombinant Pex5S. At equivalent ratios of Pex5 and BAAT, the amidation activity of BAAT-SKL was significantly more inhibited purified human SULT1E1 to wild-type and mutant forms of BAAT showed no effect on BAAT amidation activity (data not shown).
Discussion
BAAT has the important function of forming bile acid N-acylamidates of both newly formed bile acids as well as those being returned to the liver after reabsorption from the GI tract.
To aid in this function BAAT is localized both in peroxisomes and the cytosol of hepatocytes (7) (8) (9) 14) . The final steps of bile acid synthesis occur in peroxisomes and approximately 25% of BAAT is present in peroxisomes to amidate the newly formed bile acids. Bile acids that have been deamidated by bacteria in the GI tract before reabsorption are efficiently removed by hepatocytes from portal blood and amidated in the cytosol prior to being secreted into the biliary system (1).
Interaction of proteins with a PTS-1 sequence with Pex5 is involved in the translocation of many proteins into peroxisomes (24) . The typical high activity PTS-1 sequence is -SKL.
However, BAAT possesses a degenerate PTS-1 sequence at its carboxy-terminus that may be involved with the differential distribution of BAAT between the cytosolic and peroxisomal with Pex5 is supported by the observation that all three proteins were immunoprecipitated with Pex5 using the rabbit anti-BAAT antibody, and both wild-type and BAAT-S activity were inhibited by Pex5S. Since BAAT-12aa and Pex5 were not immunoprecipitated together, a relatively strong interaction is apparently occurring between Pex5 and the last 12aa of BAAT that does not require a PTS-1 sequence. Whether this interaction is sufficient to allow peroxisomal localization in cells remains unknown.
The carboxy-terminus of BAAT also has significant effects on the kinetic and substrate recognition properties of BAAT. The conversion of BAAT to BAAT-SKL resulted in a 2.5-fold increase in specific activity associated with a decreased K M for both taurine and glycine as substrates (Table 1) . There was no effect on the affinity for cholyl-CoA. In contrast, the deletion of the final two amino acids in BAAT-S did not alter the affinity for either glycine or taurine indicating that the insertion of the Lys in the penultimate position was responsible for the increased amidation activity. The presence of the Lys also increased resistance of amidation activity to thermal inactivation as compared to wild-type BAAT.
BAAT is capable of hydrolyzing the thioester linkage between cholate and the active site Cys (3). The alterations in the carboxy-terminus were also associated with changes in thioesterase activity. BAAT-SKL showed a 75% increase in thioesterase activity as compared to wild-type BAAT. The final 12 amino acids of BAAT were required for amidase activity; however, BAAT-12AA Trunc that lacked amidase activity still possessed more thioesterase activity than wild-type BAAT. BAAT-ex1, which lacked 150 amino acids at the amino-terminus, was not capable of catalyzing amidase activity but still possessed the same thioesterase activity as wild-type BAAT.
The ability of BAAT to retain thioesterase activity while losing amidase activity may allow for mutations resulting in loss of bile acid amidate formation while still catalyzing bile acid CoA hydrolysis. by guest, on 
